Sierra-Madero, J. G., Ellenberg, S., Rassool, M. S., Tierney, A., Belaunzarán-Zamudio, P. F., López-Martínez, A., . . . Lederman, M. M. (2014). A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of a Chemokine Receptor 5 (CCR5) Antagonist to Decrease the Occurrence of Immune Reconstitution Inflammatory Syndrome in HIV-Infection: The CADIRIS Study. Lancet HIV.
Style de citation ChicagoSierra-Madero, Juan G., et al. "A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of a Chemokine Receptor 5 (CCR5) Antagonist to Decrease the Occurrence of Immune Reconstitution Inflammatory Syndrome in HIV-Infection: The CADIRIS Study." Lancet HIV 2014.
Style de citation MLASierra-Madero, Juan G., et al. "A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of a Chemokine Receptor 5 (CCR5) Antagonist to Decrease the Occurrence of Immune Reconstitution Inflammatory Syndrome in HIV-Infection: The CADIRIS Study." Lancet HIV 2014.